[1]梁思琦,贾红玲,张杰,等.粪便钙卫蛋白与溃疡性结肠炎的研究进展[J].慢性病学杂志,2017,(11):1217-1220.
点击复制
粪便钙卫蛋白与溃疡性结肠炎的研究进展(PDF)
《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]
- 卷:
- 期数:
- 2017年11期
- 页码:
- 1217-1220
- 栏目:
- 综述
- 出版日期:
- 2017-11-25
文章信息/Info
- Title:
- -
- 作者:
- 梁思琦1; 贾红玲2; 张杰2; 冯丹丹3; 郭建超3; 胡勤敏3; 苏连明2
- 1. 牡丹江医学院研究生院，黑龙江牡丹江157011； 2. 牡丹江医学院附属红旗医院消化内科，黑龙江牡丹江157011 3. 牡丹江医学院研究生院，黑龙江牡丹江157011
- Author(s):
- -
- Keywords:
- -
- 分类号:
- R574.62
- DOI:
- -
- 摘要:
- 钙卫蛋白（calprotectin） 是由Fagerhol 于1980 年从中性粒细胞中分离发现的一种新型急性炎症标志物， 是中性粒细胞更新的标志物，具有抗炎、抗微生物、参与细胞信号传递等多种生物学功能。研究表明，粪便钙卫 蛋白与炎症性肠病、大肠癌等均有关系，本文就粪便钙卫蛋白与溃疡性结肠炎致病过程、活动性评估、预后评价 的研究进展作一综述。
- Abstract:
- -
参考文献/References:
[1] Kope?-M?drek M, Widuchowska M, Kucharz EJ，Calprotectin
in rheumatic diseases: a review [J]. Reumatologia,
2016,54(6):306-309.
[2] Fagerhol MK, Dale I, Andersson T. A radioimmunoassay
for a granulocyte protein as a marker in studies on the
turnover of such cells [J]. Bull Eur Physiopathol Respir,
1980(16):273-282.
[3] Leclerc E, Vetter SW. The role of S100 proteins and
their receptor RAGE in pancreatic cancer [J]. Biochimica
Et Biophysica Acta, 2015,1852(12):2706-2711.
[4] Hsu K, Champaiboon C, Guenther BD, et al. Anti- infective
protective properties of 100 calgranulins [J]. Antiinflamm
Antiall- ergy Agents Med Chem, 2009,8(4):290-
305.
[5] van Langenberg DR, Della GP, Warmington SA, et al.
Objectively measured muscle fatigue in Crohn's disease:
correlation with self- reported fatigue and associated factors
for clinical application [J]. J Crohns & Colitis, 2014,8(2):
137-146.
[6] D’ Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin
is a surrogate marker for endoscopic lesions in inflammatory
bowel disease [J]. Inflamm Bowel Dis, 2012,18
(12):2218-2224.
[7] Wan SG, Taccioli C, Jiang Y, et al. Zinc deficiency activates
S100A8 inflammation in the absence of COX- 2 and
promotes murine oral- esophageal tumor progression [J].
Int J Cancer, 2011,129(2):331-345.
[8] Kanik A, Baran M, Ince FD, et al. Faecal calprotectin
levels in children with Henoch- Schonlein purpura: is this a
new marker for gastrointestinal involvement [J]. Eur J Gastroenterol
Hepatol, 2015,27(3):254-258.
[9] Zhao X, Pan S, Liu C. Effect of S100 calcium binding
protein A12 on the pathogenesis of preeclampsia [J]. Zhonghua
Fu Chan Ke Za Zhi, 2015,50(3):183-187.
[10] 钱家鸣,杨红.中国炎症性肠病研究的历史回顾现状和展望[J].中
国实用内科杂志,2015,35(9):727-730.
[11] Mosli MH, Zou G, Garg SK, et al. C- reactive protein，
fecal calprotectin，and stool lactoferrin for detection of endoscopic
activity in symptomatic inflammatory bowel disease
patients: a systematic review andmeta- analysis [J].
Am J Gastroenterol, 2015,110(6):802-819.
[12] Jung SH, Saxena A, Kaur K, et al. The role of adipose
tissue- associated macrophages and T lymphocytes in the
pathogenesis of inflammatory bowel disease [J]. Cytokine,
2013,61(2):459-468.
[13] 周琳,周光炎,路丽明.IL-10 的双向免疫调节作用[J].细胞与分
子免疫学杂志,2012,28(10):1100-1103．
[14] Kumawat AK, Strid H, Tysk C, et al. Microscopic colitis
patients demonstrate a mixed Th17/Tc17 and Th1/Tc1
mucosal cytokineprofile [J]. Mol Immunol, 2013,55(3- 4):
355-364．
[15] 王坤,宣秀敏,王莲,等. 溃疡性结肠炎模型大鼠炎性细胞因子及
钙卫蛋白的表达及其相关性分析[J]. 细胞与分子免疫学杂志,
2014,30(3):278-283.
[16] Sandborn WJ, Panés J, Zhang H, et al. Correlation Between
Concentrations of Fecal Calprotectin and Outcomes
of Patients With Ulcerative Colitis in a Phase 2 Trial [J].
Gastroenterology, 2015,150(1):96-102.
[17] Theede K， Holck S， Tbsen P, et al. Level of Fecal Calprotectin
Correlates With Endoscopic and Histologic Inflammation
and Identifies Patients With Mucosal Healing
in Ulcerative Colitis [J]. Clin Gastroenterol Hepatol, 2015,13(11):1929-1936.
[18] Zamani H, Barzin G, Yousefinia M, et al. Diagnostic value
of fecal calprotectin in patient with ulcerative colitis [J].
Middle East J Dig Dis, 2013,5(2):76-80.
[19] 张伟,杨银利,吴洁琼,等. 溃疡性结肠炎患者粪便钙卫蛋白水平
与病情严重程度相关性[J]. 中华实用诊断与治疗杂志,2016,30
(11):1114-1115.
[20] 肖林,王孟春. 快速粪便钙卫蛋白检测卡在溃疡性结肠炎患者病
情评估中的作用[J]. 胃肠病学和肝病学杂志,2017,26(1):56-
58.
[21] Burri E, Beglinger C, Felten SV, et al. Fecal Calprotectin
and the Clinical Activity Index Are Both Useful to Monitor
Medical Treatment in Patients with Ulcerative Colitis
[J]. Digestive Diseases & Sciences, 2015,60(2):485-491.
[22] Theede K, Kiszka- Kanowitz M, Nielsen AM, et al. The
correlation between fecal calprotectin, simple clinical colitis
activity index and biochemical markers in ulcerative colitis
during high- dose steroid treatment [J]. Scandinavian Journal
of Gastroenterology, 2014,49(4):418-423.
[23] Gisbert JP, Bermejo F, Pérez- Calle JL, et al. P039 -
Faecal calprotectin and lactoferrin for the prediction of inflammatory
bowel disease relapse [J]. Inflammatory Bowel
Diseases, 2009,15(8):1190.
[24] Yamamoto T, Shiraki M, Bamba T, et al. Faecal calprotectin
and lactoferrin as markers for monitoring disease activity
and predicting clinical recurrence in patients with
Crohn’s disease after ileocolonic resection: A prospective
pilot study [J]. United Eur Gastroenterol J, 2013,1(5):368.
[25] Wright EK, Kamm MA, Cruz PD, et al. Measurement of
Fecal Calprotectin Improves Monitoring and Detection of
Recurrence of Crohn's Disease After Surgery [J]. Gastroenterology,
2015,148(5):938-947.
[26] Jaureguiamezaga A, Lópezcerón M, Aceituno M, et al. Accuracy
of advanced endoscopy and fecal calprotectin for
prediction of relapse in ulcerative colitis: a prospective
study [J]. Inflammatory Bowel Diseases, 2014,20(7):1187-
1193.
[27] Zhulina Y, Cao Y, Amcoff K, et al. The prognostic significance
of faecal calprotectin in patients with inactive inflammatory
bowel disease [J]. Alimentary Pharmacology &
Therapeutics, 2016,44(5):495-504.
[28] Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin
[J]. Gastroenterol Clin North Am, 2012,41(2):483-
495．
[29] Kant P, Fazakerley R, Hull MA. Faecal calprotectin levels
before and after weight loss in obese and overweight
subjects [J]. Int J Obes(Lond), 2013,37(2):317-319.
备注/Memo
- 备注/Memo:
- 基金项目：牡丹江市科学计划项目（Z2016S0062） 作者简介：梁思琦，在读硕士，住院医师，研究方向：肠 道微生态 通讯作者：苏连明，Email：sulianming1981@163.com
常用功能
统计/Statistics
- 摘要浏览/Viewed1034
- 全文下载/Downloads814
- 评论/Comments
